An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients

Clinica Chimica Acta

Volumn 324, Issue 1-2, 2002, Pages 45-50

  Selvaraj, N ^a   Bobby, Zachariah ^a   Das, Ashok Kumar ^a   Ramesh, R ^a   Koner, Bidhan Chandra ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diabetes; Dialysis; Fructosamine; Oxidative stress; Renal failure

Indexed keywords

ALBUMIN; ASCORBIC ACID; FREE RADICAL; FRUCTOSAMINE; GLUTATHIONE; LIPID PEROXIDASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

ADULT; ALBUMINS; ANTIOXIDANTS; CASE-CONTROL STUDIES; DIALYSIS; FEMALE; FRUCTOSAMINE; GLYCOSYLATION; HUMANS; KIDNEY FAILURE, CHRONIC; LIPID PEROXIDES; LOGISTIC MODELS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 0036776097     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(02)00211-5     Document Type: Article

References (36)

1. Lazarus J.M., Brenner B.M. Chronic renal failure. Fauci A.S., Braunwald E., Issenlbacher K.J. Harrison's principles of internal medicine. 1998;1513-1520 McGraw-Hill, New York.
2. Kehrer J.P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol. 23:1993;21-48.
3. Baud L., Ardaillou K. Involvement of reactive oxygen species in kidney damage. Br. Med. Bull. 49:1993;621-629.
4. Baral N., Koner B.C., Karki P., Ramprasad C., Lamsal M., Koiral S. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in heterogeneous Nepali population: the implication of measuring glycated hemoglobin. Singap. Med. J. 41:2000;264-267.
5. Hori D., Yan S.D., Ogawa S.et al. The receptor for advanced glycation end products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol. Dial Transplant. 11(Suppl. 5):1996;13-16.
6. Raj D.S., Choudhury D., Welbourne T.C., Levi M. Advanced glycation end products: a nephrologist's perspective. Am. J. Kidney Dis. 35(3):2000;365-380.
7. Miyata T., Wada Y., Cai Z.et al. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end stage renal failure. Kidney Int. 51:1997;1170-1181.
8. Miyata T., Izuhara Y., Sakai H., Kurokawa K. Carbonyl stress: increased carbonyl modification of tissue and cellular proteins in uremia. Perit. Dial. Int. 19:1999;S58-S61.
9. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem. J. 245:1987;243-250.
10. Lindsay R.M., Smith W., Lee W.K., Dominiczak M.H., Baird J.D. The effect of delta gluconolactone, an oxidized analogue of glucose, on the non-enzymatic glycation of human and rat haemoglobin. Clin. Chim. Acta. 263:1997;239-247.
11. Descamps-Latscha B., Witkosarsat V. Importance of oxidatively modified proteins in chronic renal failure. Kidney Inter., Suppl. 78:2001;S108-S113.
12. Miyata T., van Ypersele de Strihou C., Kurokawa K., Baynes J.W. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 55(2):1999;389-399.
13. Miyata T., Ueda Y., Saito A., Kurokawa K. 'Carbonyl stress' and dialysis-related amyloidosis. Nephrol. Dial. Transplant. 15(1):2000;25-28.
14. Dawnay A., Millae D.J. The pathogenesis and consequences of AGE formation in uremia and its treatment. Cell. Mol. Biol. 44:1998;1081-1094.
15. Miyata T., Kurokawa K., van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Inter., Suppl. 76:2000;S120-S125.
16. Miyata T., Sugiyama S., Saito A., Kurokawa K. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Inter., Suppl. 78:2001;S25-S31.
17. Weiss M.F., Erhard P., Kader-Attia F.A., Wu Y.C.et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int. 57(6):2000;2571-2585.
18. Friedlander M.A., Wu Y.C., Schulak J.A., Monnier V.M., Hricik D.E. Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am. J. Kidney Dis. 25:1995;445-451.
19. Kumano K., Yokota S., Sakai T.et al. Kinetic analysis of furosine and pentosidine in CAPD patients. Adv. Perit. Dial. 13:1997;53-57.
20. Loughrey C.M., Young I.S., Hightbody J.H., McMaster D., MuNamee P.T., Trimble E.R. Oxidative stress in hemodialysis. Q. J. Med. 87:1994;679-683.
21. Beutle E., Duron O., Kelly B.M. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61:1963;882-888.
22. McCormick D.B., Greene H.L. Vitamins. Burtis C.A., Ashwood E.R. Tietz textbook of clinical chemistry. 1999;999-1028 Harcourt Brace & Company Asia, Singapore.
23. Yagi K. Methods of enzymology. vol. 105:1984;328-331 Academic Press, London.
24. Tas S., Zein el Din R.R. Automated fructosamine assay with improved accuracy used to quantify nonenzymatic glycation of serum proteins in diabetes mellitus and CRF. Clin. Chem. 36:1990;1825-1830.
25. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 58(6):2000;2571-2578.
26. Chugh S.N., Jain S., Agrawal N., Sharma A. Evaluation of oxidative stress before and after hemodialysis in chronic renal failure. J. Assoc. Phys. India. 48:2000;981-984.
27. Annuk M., Fellstrom B., Akerblom O., Zilmar K., Vihalemm T., Zilmer M. Oxidative stress markers in pre-uremic patients. Clin. Nephrol. 56(4):2001;308-314.
28. Mimic-Oka J., Simic T., Djukanovic L., Reljic Z., Davicevic Z. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clin. Nephrol. 51(4):1999;233-241.
29. Lyons T.J. Glycation, oxidation and glycoxidation reactions in the development of diabetic complications. Contrib. Nephrol. 112:1995;1-10.
30. Wolff S.P. Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications. Br. Med. Bull. 49:1993;642-652.
31. Davie S., Gould B., Yudkin J. Effect of vitamin C on glycosylation of proteins. Diabetes. 41:1992;167-173.
32. Ceriello A., Guighano D., Quatraro A., Donzella C., Diaplo G., Lefebvre P.J. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications. Diabetes Care. 14:1991;68-72.
33. Armbruster D.A. Fructosamine: structure, analysis and clinical usefulness. Clin. Chem. 33(12):1987;2153-2163.
34. Olufemi S., Talwar D., Robb D.A. The relative extent of glycation of hemoglobin and albumin. Clin. Chim. Acta. 163:1987;125-136.
35. Himmelfarb J., McMonagle E. Albumin is the major plasma target of oxidant stress in uremia. Kidney Int. 60(1):2001;358-363.
36. Morgan L., Marench C.B., Jeffcoate W.J., Morgan A.G. Glycated proteins as indices of glycemic control in diabetic patients with chronic renal failure. Diabet. Med. 13(6):1996;514-519.